Generic filters
Exact matches only
Search in title
Search in excerpt
Search in content
Filter by content type
Choose One/Select all
Comments
Taxonomy terms
Users
Filter by Categories
Business/Economy
Commentary
Criminal Justice
Defense/Military
Environment
Education
Gov & Politics
Health
Human Rights
Immigration
Labor
Lifestyle
Media/Showbiz
Misinformation
Science and Tech
Viral Content
World
Sunday, May 19, 2024
Criminal Justice

Supreme Court Postpones Crucial Abortion Pill Ruling

Mifepristone
“Lek Prevent zawierający mifepriston” by Yuchacz is licensed under CC BY-SA 4.0.

An anticipated ruling on access to mifespristone, one of two medications used in a majority of abortions in the U.S., was delayed by the U.S. Supreme Court on Wednesday, giving the court until Friday to rule on the availability of the pill.

The court is
considering a ruling handed down earlier this month by the 5th Circuit Court of Appeals, which would terminate Food and Drug Administration (FDA) policies adopted in 2016 to improve access to mifepristone. That year, the agency allowed patients to obtain the pill through the mail, retail pharmacies, and telemedicine prescriptions.

If allowed to take effect, the appeals court ruling would also change the FDA’s approval of the drug to seven weeks of pregnancy instead of the current 10 weeks.

The appeals court ruling only partially blocked
an early decision by right-wing U.S. District Judge Matthew Kacsmaryk, which would entirely suspend the FDA’s approval of mifepristone, more than two decades after the drug became legally available.

The FDA and drug companies have warned that even allowing the 5th Circuit Court of Appeals’ ruling to go forward would drastically cut access to mifepristone, which has been used by more than 5 million people in the U.S. since its approval.

Reproductive rights groups on Wednesday
emphasized that “mifepristone remains available” until at least Friday, while warning that a ruling in favor of the lower courts’ decisions will harm millions of people who rely on the medication.

“There is only one acceptable outcome here,” said the Guttmacher Institute, a research and policy group.

Allowing the lower courts’ rulings to move forward would also “set a dangerous precedent that will severely hamper the development and approval of lifesaving new drugs—and even put critical medications that we currently rely on at risk,”
said the ACLU.

Supreme Court observers were left to wonder Wednesday evening whether the ruling was delayed to give time to a liberal justice to write a dissent regarding a denial of a stay on the appeals court’s decision, or for a conservative justice to dissent against a stay.

NARAL Pro-Choice America President Mini Timmaraju expressed hope that “the anti-choice extremists on the court” will “throw in the towel and accept reality: the science, the facts, and the law are all on the side of legal and accessible medication abortion.”

“As this case continues, safe and effective medication abortion with mifepristone in all 50 states remains in peril. The Supreme Court knows that siding with extreme Trump judges to restrict medication abortion will ignite the biggest political firestorm since
Roe v. Wade was overturned,” said Timmaraju. “The lower courts’ decisions have been entirely baseless.”

Generic filters
Exact matches only
Search in title
Search in excerpt
Search in content
Filter by content type
Choose One/Select all
Comments
Taxonomy terms
Users
Filter by Categories
Business/Economy
Commentary
Criminal Justice
Defense/Military
Environment
Education
Gov & Politics
Health
Human Rights
Immigration
Labor
Lifestyle
Media/Showbiz
Misinformation
Science and Tech
Viral Content
World